Actelion
Actelion was a Swiss biopharmaceutical company primarily focused on the development of drugs for pulmonary arterial hypertension. In 2017, the company was acquired by the American multinational corporation Johnson & Johnson and currently operates as a subsidiary within the Janssen Pharmaceutical Companies.
Brand Identity Data
HQ Country
Switzerland
HQ City
Allschwil
Founded
1997
EU Headquartered
Yes
EU Manufactured
Yes
Stock Exchange
Private
Repair / Recycling
No
Ethical Certifications
None verified
Verified on July 22, 2026